wire - news in brief

« BACK

Pharmacology



Results 1 - 9 of 9.


Health - Pharmacology - 20.07.2021
Impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis
Impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis
The ROMANOV study found impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis The ROMANOV study found impaired humoral

Pharmacology - 22.03.2021
Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis patients
Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis patients
Publication of CIRI in Sciences advances on March 19, 2021. Toxic epidermal necrolysis (TEN) is a life-threatening cutaneous adverse drug reaction.

Health - Pharmacology - 15.04.2020
Covid-19: CIRI mobilizes its teams to understand the immune response against Coronavirus in patients
A CIRI project, in collaboration with HCL, has united CIRI immunologists to work on understanding the immune response to Coronavirus in patients.

Health - Pharmacology - 27.05.2019
Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy
Publication by the International Center for Infectiology Research (CIRI) in The Journal of Allergy and Clinical Immunology on January 14, 2019.

Pharmacology - Life Sciences - 11.05.2018
Farnesoid X receptor-- is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo
Farnesoid X receptor- is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo Abstract: Hepatitis B virus (HBV) infection and bile acid (BA) metabolism are in